Alphabet’s Isomorphic Labs raises $5B to accelerate drug discovery with AI

SiliconANGLE
Read onSiliconANGLE· 4 min
Alphabet's Isomorphic Labs secured $5 billion in funding led by Greenoaks and Sequoia Capital to advance its AI-driven drug discovery platform, IsoDDE, which accelerates identifying drug targets and designing compounds without traditional 3D protein modeling.
Full coverage from 6 sourcesIsomorphic Labs raises $5 billion to advance AI drug discoverySee full coverage

More in Healthcare